Yi Qingqing 4
4 · BeOne Medicines Ltd. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
BeOne (ONC) Director Yi Qingqing Sells 235 ADSs
What Happened
- Yi Qingqing, a director of BeOne Medicines Ltd. (ONC), disposed of 235 American Depositary Shares (ADSs) on 2026-06-01. The ADSs were sold at $279.13 per share for proceeds of $65,596. The filing reports the sale was effected in connection with tax withholding tied to vested restricted share units (RSUs).
Key Details
- Transaction date and price: 2026-06-01 — 235 ADSs @ $279.13 each; total $65,596.
- Shares owned after transaction: Not disclosed in the provided filing details.
- Footnote F1: Each ADS represents 13 ordinary shares.
- Footnote F2: The sale was a mandatory tax-withholding disposition under the reporting person's RSU award agreement (i.e., shares sold to cover taxes on vesting). RSUs vest on the earlier of the first anniversary of grant or the next annual general meeting; vesting may accelerate on change in control and generally ceases if the director resigns unless the board decides otherwise.
- Timeliness: Filing dated 2026-06-03 for a 2026-06-01 transaction — appears timely under standard Form 4 reporting rules.
Context
- This transaction is a withholding sale to satisfy tax obligations on vested RSUs rather than a discretionary open-market liquidation for investment purpose; such filings are typically routine and do not necessarily indicate the insider’s view on the company’s prospects.
Insider Transaction Report
Form 4
Yi Qingqing
Director
Transactions
- Sale
American Depositary Shares
[F1][F2]2026-06-01$279.13/sh−235$65,596→ 0 total
Holdings
- 24,271
Ordinary Shares
Footnotes (2)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of restricted share units ("RSUs") previously granted to the Reporting Person. The RSUs shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
Signature
s/ Qingqing Yi|2026-06-03